GLYC (GlycoMimetics, Inc.) Wutah bathi ing taun lumaku

Simbol resmi perusahaan GlycoMimetics (GLYC)

GlycoMimetics, Inc. (GLYC) is undergoing a period of rigorous reorganization and asset consolidation following failures in clinical trials of its lead drug candidate. The annual trend in net income per share reflects the current market valuation, where 96.70 indicates the current level. Meanwhile, the patent portfolio in glycobiology is attracting strategic partners, protecting capital. A unique approach to cancer cell metabolism is laying the foundation for future revenues.

GLYC (GlycoMimetics Inc.) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 16.06.2025

Rincian metrik komprehensif lan analitis glycomimetics.com (GLYC)

- rega saham lan prakiraan rega para ahli:
Rega GlycoMimetics|GLYC - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar GlycoMimetics, Inc.|GLYC - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham GlycoMimetics|GLYC - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas glycomimetics.com|GLYC - Total Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal GlycoMimetics, Inc.|GLYC - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal GlycoMimetics|GLYC - Gunggung utang perusahaan|Utang-utang marang nilai buku GlycoMimetics, Inc.|GLYC - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan GlycoMimetics|Rasio jangkoan perantara glycomimetics.com
- indikator pendapatan resik lan kelipatan nilai:
GLYC - Penghasilan resik|Bathi resik mangsa ngarep GlycoMimetics, Inc.|GLYC - Pangali P/E|Pangali mangsa ngarep rega marang bathi GlycoMimetics|GLYC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GlycoMimetics, Inc.|GLYC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku GlycoMimetics|GLYC - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan glycomimetics.com|GLYC - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep GlycoMimetics, Inc.
- informasi babagan volume dodolan lan pendapatan:
GLYC - Dodolan perusahaan|Volume dodolan sing dikarepake perusahaan GlycoMimetics|GLYC - Multiplikator P/S|Prakiraan rega marang pendapatan GlycoMimetics, Inc.
Pambiji fundamental:GLYC GlycoMimetics Corp
Produk mawa merek GlycoMimetics, Inc.

Investors use this indicator to evaluate profit generation efficiency and business scaling rates. The metric is calculated as the percentage deviation of current net income per share from the value for the same period last year. For GlycoMimetics, Inc. (GLYC), costs associated with the environmental modernization of production impact final margins, which is directly reflected in the annual growth rate of net income per share.

Pesaing langsung

GMAB: Wutah bathi resik saben siji saham kanggo taun lumaku|EXEL (Exelixis Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Nuvalent Therapeutics|Wutah bathi saben saham ing taun lumaku Kymera Therapeutics (KYMR)|IDYA (ideayabio.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ELVN (Enliven Therapeutics, Inc.)|Owah-owahan bathi resik saben saham ing taun lumaku ORIC Pharmaceuticals Inc|Relay Pharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Wutah bathi resik saben saham ing taun iki|VSTM: Wutah bathi resik saben siji saham kanggo taun lumaku|GLUE (Monte Rosa Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Cullinan Oncology CGEM|Wutah bathi ing taun lumaku IMRX|C4 Therapeutics Corp - Wutah bathi saben saham ing taun iki|Black Diamond - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku RPTX|PMVP: Wutah bathi resik saben saham ing taun iki|Karyopharm Therapeutics - Wutah bathi resik saben siji saham kanggo taun lumaku|PPCB: Wutah bathi ing taun lumaku|Cyclacel - Tambahing bathi saben saham ing taun lumaku|AADI (Aadi Bioscience Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Aileron ALRN|Wutah bathi saben saham ing taun lumaku Blueprint Medicines (BPMC)|SWTX (SpringWorks Therapeutics Inc.) - Tambahing bathi saben saham ing taun lumaku